Annual report

Period2022-04-01 → 2023-03-31
Filed2023-06-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥350.7bn2022-04-01 → 2023-03-31Cons.Net sales
Revenue¥300.9bn2021-04-01 → 2022-03-31Cons.Net sales
Revenue¥278.4bn2020-04-01 → 2021-03-31dCons.Net sales (5-year summary)
Revenue¥281.2bn2019-04-01 → 2020-03-31dCons.Net sales (5-year summary)
Revenue¥277.4bn2018-04-01 → 2019-03-31dCons.Net sales (5-year summary)
Operating income¥37.9bn2022-04-01 → 2023-03-31Cons.Operating income
Operating income¥43.4bn2021-04-01 → 2022-03-31Cons.Operating income
Ordinary income¥38.7bn2022-04-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥43.2bn2021-04-01 → 2022-03-31Cons.Ordinary income
Ordinary income¥21.9bn2020-04-01 → 2021-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥16.3bn2019-04-01 → 2020-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥18.4bn2018-04-01 → 2019-03-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥39.7bn2022-04-01 → 2023-03-31Cons.Income before income taxes
Profit before tax¥41.0bn2021-04-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥21.2bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥20.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥10.6bn2020-04-01 → 2021-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.0bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥10.4bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥28.7bn2022-04-01 → 2023-03-31Cons.Profit loss
Net income¥29.4bn2021-04-01 → 2022-03-31Cons.Profit loss
Total assets¥399.2bnat 2023-03-31Cons.Assets
Total assets¥362.4bnat 2022-03-31Cons.Assets
Total assets¥306.9bnat 2021-03-31dCons.Total assets (5-year summary)
Total assets¥283.9bnat 2020-03-31dCons.Total assets (5-year summary)
Total assets¥287.1bnat 2019-03-31dCons.Total assets (5-year summary)
Total liabilities¥143.9bnat 2023-03-31Cons.Liabilities
Total liabilities¥137.9bnat 2022-03-31Cons.Liabilities
Net assets / equity¥255.3bnat 2023-03-31Cons.Net assets
Net assets / equity¥224.6bnat 2022-03-31Cons.Net assets
Net assets / equity¥191.5bnat 2021-03-31dCons.Net assets
Net assets / equity¥181.3bnat 2020-03-31dCons.Net assets (5-year summary)
Net assets / equity¥179.8bnat 2019-03-31dCons.Net assets (5-year summary)
Cash and deposits¥96.8bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥80.4bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥91.8bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥75.7bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥62.9bnat 2021-03-31dCons.Cash and cash equivalents
Cash & equivalents¥44.5bnat 2020-03-31dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥48.6bnat 2019-03-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥45.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥16.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥27.1bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥11.7bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥13.5bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥10.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥6.7bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥3.7bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥9.2bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥22.2bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥4.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.5bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥11.7bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥4.2bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥107.262022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥105.052021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥53.482020-04-01 → 2021-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥45.112019-04-01 → 2020-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥52.152018-04-01 → 2019-03-31dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥1,031.6at 2023-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥912.58at 2022-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥793.53at 2021-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥747.39at 2020-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥742.36at 2019-03-31dCons.Net assets per share (5-year summary)
Equity ratio51.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio49.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio51.1%at 2021-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio52.1%at 2020-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio51.6%at 2019-03-31dCons.Equity to asset ratio (5-year summary)
ROE11.0%2022-04-01 → 2023-03-31Cons.Rate of return on equity (5-year summary)
ROE12.3%2021-04-01 → 2022-03-31Cons.Rate of return on equity (5-year summary)
ROE6.9%2020-04-01 → 2021-03-31dCons.Rate of return on equity (5-year summary)
ROE6.1%2019-04-01 → 2020-03-31dCons.Rate of return on equity (5-year summary)
ROE7.1%2018-04-01 → 2019-03-31dCons.Rate of return on equity (5-year summary)
Employees5,171at 2023-03-31Cons.Number of employees
Employees4,934at 2022-03-31Cons.Number of employees
Employees4,748at 2021-03-31dCons.Number of employees
Employees4,680at 2020-03-31dCons.Number of employees
Employees4,493at 2019-03-31dCons.Number of employees
Revenue¥10.8bn2022-04-01 → 2023-03-31StandaloneOperating revenue1
Revenue¥9.2bn2021-04-01 → 2022-03-31StandaloneOperating revenue1
Revenue¥6.0bn2020-04-01 → 2021-03-31dStandaloneOperating revenue1 (5-year summary)
Revenue¥5.8bn2019-04-01 → 2020-03-31dStandaloneOperating revenue1 (5-year summary)
Revenue¥5.1bn2018-04-01 → 2019-03-31dStandaloneOperating revenue1 (5-year summary)
Operating income¥6.0bn2022-04-01 → 2023-03-31StandaloneOperating income
Operating income¥4.6bn2021-04-01 → 2022-03-31StandaloneOperating income
Ordinary income¥6.8bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥5.1bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥2.0bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.8bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.1bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥7.4bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Profit before tax¥5.0bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Net income¥7.1bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥4.9bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥1.8bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥2.4bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥1.8bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Total assets¥124.4bnat 2023-03-31StandaloneAssets
Total assets¥134.7bnat 2022-03-31StandaloneAssets
Total assets¥122.2bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥113.7bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥125.6bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥50.1bnat 2023-03-31StandaloneLiabilities
Total liabilities¥60.7bnat 2022-03-31StandaloneLiabilities
Net assets / equity¥74.4bnat 2023-03-31StandaloneNet assets
Net assets / equity¥74.0bnat 2022-03-31StandaloneNet assets
Net assets / equity¥72.3bnat 2021-03-31dStandaloneNet assets
Net assets / equity¥70.2bnat 2020-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥76.0bnat 2019-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥19.1bnat 2023-03-31StandaloneCash and deposits
Cash and deposits¥28.7bnat 2022-03-31StandaloneCash and deposits
EPS (basic)¥35.782022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥24.792021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥9.242020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥11.872019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥8.862018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥382022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥372021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥212020-04-01 → 2021-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥202019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥182018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥376.3at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥374.23at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥365.52at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥354.93at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥380.84at 2019-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio59.8%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio54.9%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio59.1%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio61.7%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio60.5%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE9.5%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE6.7%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE2.6%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE3.2%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE2.3%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued199,699,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued199,699,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued199,699,000at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued199,699,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued201,699,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees190at 2023-03-31StandaloneNumber of employees
Employees184at 2022-03-31StandaloneNumber of employees
Employees184at 2021-03-31dStandaloneNumber of employees
Employees183at 2020-03-31dStandaloneNumber of employees
Employees183at 2019-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 101
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentscapex2022-04-01 → 2023-03-31¥100m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2022-04-01 → 2023-03-31¥230m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2023-03-31312 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2023-03-31¥30.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2023-03-31¥13.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2023-03-31¥17.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2023-03-31¥18.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2023-03-31¥2.3bn
Reconciling Itemsreconcilingcapex2022-04-01 → 2023-03-31¥79m
Reconciling Itemsreconcilingdepreciation2022-04-01 → 2023-03-31¥326m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2023-03-31−¥18.8bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2023-03-31−¥18.8bn
Reconciling Itemsreconcilingsegment assetsat 2023-03-31¥39.8bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2023-03-31−¥601m
Takara Bio Groupreportable segmentcapex2022-04-01 → 2023-03-31¥6.5bn
Takara Bio Groupreportable segmentdepreciation2022-04-01 → 2023-03-31¥4.0bn
Takara Bio Groupreportable segmentemployeesat 2023-03-311793 pure
Takara Bio Groupreportable segmentrevenue2022-04-01 → 2023-03-31¥78.1bn
Takara Bio Groupreportable segmentrevenue external2022-04-01 → 2023-03-31¥78.1bn
Takara Bio Groupreportable segmentrevenue intersegment2022-04-01 → 2023-03-31¥2m
Takara Bio Groupreportable segmentsegment assetsat 2023-03-31¥129.2bn
Takara Bio Groupreportable segmentsegment profit2022-04-01 → 2023-03-31¥20.5bn
Takara Shuzoreportable segmentcapex2022-04-01 → 2023-03-31¥2.8bn
Takara Shuzoreportable segmentdepreciation2022-04-01 → 2023-03-31¥2.5bn
Takara Shuzoreportable segmentemployeesat 2023-03-311243 pure
Takara Shuzoreportable segmentrevenue2022-04-01 → 2023-03-31¥122.9bn
Takara Shuzoreportable segmentrevenue external2022-04-01 → 2023-03-31¥122.1bn
Takara Shuzoreportable segmentrevenue intersegment2022-04-01 → 2023-03-31¥805m
Takara Shuzoreportable segmentsegment assetsat 2023-03-31¥90.0bn
Takara Shuzoreportable segmentsegment profit2022-04-01 → 2023-03-31¥4.9bn
Takara Shuzo International Groupreportable segmentcapex2022-04-01 → 2023-03-31¥4.7bn
Takara Shuzo International Groupreportable segmentdepreciation2022-04-01 → 2023-03-31¥2.0bn
Takara Shuzo International Groupreportable segmentemployeesat 2023-03-311633 pure
Takara Shuzo International Groupreportable segmentrevenue2022-04-01 → 2023-03-31¥137.5bn
Takara Shuzo International Groupreportable segmentrevenue external2022-04-01 → 2023-03-31¥137.3bn
Takara Shuzo International Groupreportable segmentrevenue intersegment2022-04-01 → 2023-03-31¥226m
Takara Shuzo International Groupreportable segmentsegment assetsat 2023-03-31¥121.3bn
Takara Shuzo International Groupreportable segmentsegment profit2022-04-01 → 2023-03-31¥10.8bn
—segment totalcapex2022-04-01 → 2023-03-31¥14.0bn
—segment totaldepreciation2022-04-01 → 2023-03-31¥8.6bn
—segment totalemployeesat 2023-03-314669 pure
—segment totalrevenue2022-04-01 → 2023-03-31¥338.5bn
—segment totalrevenue external2022-04-01 → 2023-03-31¥337.5bn
—segment totalrevenue intersegment2022-04-01 → 2023-03-31¥1.0bn
—segment totalsegment assetsat 2023-03-31¥340.5bn
—segment totalsegment profit2022-04-01 → 2023-03-31¥36.3bn
Total Of Reportable Segments And Otherssegment totalcapex2022-04-01 → 2023-03-31¥14.1bn
Total Of Reportable Segments And Otherssegment totaldepreciation2022-04-01 → 2023-03-31¥8.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2023-03-31¥369.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2023-03-31¥350.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2023-03-31¥18.8bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-03-31¥359.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2023-03-31¥38.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentscapex2021-04-01 → 2022-03-31¥208m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2021-04-01 → 2022-03-31¥238m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2022-03-31¥30.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2022-03-31¥12.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2022-03-31¥18.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2022-03-31¥19.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2022-03-31¥2.2bn
Reconciling Itemsreconcilingcapex2021-04-01 → 2022-03-31¥194m
Reconciling Itemsreconcilingdepreciation2021-04-01 → 2022-03-31¥366m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2022-03-31−¥19.4bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2022-03-31−¥19.4bn
Reconciling Itemsreconcilingsegment assetsat 2022-03-31¥46.6bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2022-03-31−¥379m
Takara Bio Groupreportable segmentcapex2021-04-01 → 2022-03-31¥13.2bn
Takara Bio Groupreportable segmentdepreciation2021-04-01 → 2022-03-31¥3.6bn
Takara Bio Groupreportable segmentrevenue2021-04-01 → 2022-03-31¥67.7bn
Takara Bio Groupreportable segmentrevenue external2021-04-01 → 2022-03-31¥67.7bn
Takara Bio Groupreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥0
Takara Bio Groupreportable segmentsegment assetsat 2022-03-31¥115.7bn
Takara Bio Groupreportable segmentsegment profit2021-04-01 → 2022-03-31¥28.9bn
Takara Shuzoreportable segmentcapex2021-04-01 → 2022-03-31¥1.8bn
Takara Shuzoreportable segmentdepreciation2021-04-01 → 2022-03-31¥2.6bn
Takara Shuzoreportable segmentrevenue2021-04-01 → 2022-03-31¥119.7bn
Takara Shuzoreportable segmentrevenue external2021-04-01 → 2022-03-31¥118.9bn
Takara Shuzoreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥820m
Takara Shuzoreportable segmentsegment assetsat 2022-03-31¥90.4bn
Takara Shuzoreportable segmentsegment profit2021-04-01 → 2022-03-31¥4.1bn
Takara Shuzo International Groupreportable segmentcapex2021-04-01 → 2022-03-31¥844m
Takara Shuzo International Groupreportable segmentdepreciation2021-04-01 → 2022-03-31¥1.7bn
Takara Shuzo International Groupreportable segmentrevenue2021-04-01 → 2022-03-31¥102.2bn
Takara Shuzo International Groupreportable segmentrevenue external2021-04-01 → 2022-03-31¥101.9bn
Takara Shuzo International Groupreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥265m
Takara Shuzo International Groupreportable segmentsegment assetsat 2022-03-31¥89.8bn
Takara Shuzo International Groupreportable segmentsegment profit2021-04-01 → 2022-03-31¥8.5bn
—segment totalcapex2021-04-01 → 2022-03-31¥15.8bn
—segment totaldepreciation2021-04-01 → 2022-03-31¥7.8bn
—segment totalrevenue2021-04-01 → 2022-03-31¥289.6bn
—segment totalrevenue external2021-04-01 → 2022-03-31¥288.5bn
—segment totalrevenue intersegment2021-04-01 → 2022-03-31¥1.1bn
—segment totalsegment assetsat 2022-03-31¥296.0bn
—segment totalsegment profit2021-04-01 → 2022-03-31¥41.5bn
Total Of Reportable Segments And Otherssegment totalcapex2021-04-01 → 2022-03-31¥16.0bn
Total Of Reportable Segments And Otherssegment totaldepreciation2021-04-01 → 2022-03-31¥8.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2022-03-31¥320.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2022-03-31¥300.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2022-03-31¥19.4bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-03-31¥315.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2022-03-31¥43.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,846
ItemContextValueUnit
Number of employeesCurrentYearInstant_jpcrp030000-asr_E00396-000TakaraShuzoInternationalGroupReportableSegmentsMember1633
Number of employeesCurrentYearInstant_jpcrp030000-asr_E00396-000TakaraBioGroupReportableSegmentsMember1793
Number of employeesCurrentYearInstant_ReportableSegmentsMember4669
Number of employeesCurrentYearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember312
Number of employeesCurrentYearInstant_CorporateSharedMember190
Number of employeesCurrentYearInstant5171
Number of employeesCurrentYearInstant_NonConsolidatedMember190
Average age years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember49.3
Average length of service years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember24.0
Average annual salary information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember7483000JPY
Research and development expenses research and development activitiesCurrentYearDuration8949000000JPY
Research and development expenses research and development activitiesCurrentYearDuration_jpcrp030000-asr_E00396-000TakaraShuzoReportableSegmentsMember367000000JPY
Research and development expenses research and development activitiesCurrentYearDuration_jpcrp030000-asr_E00396-000TakaraBioGroupReportableSegmentsMember8575000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration_jpcrp030000-asr_E00396-000TakaraShuzoReportableSegmentsMember2763000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration_jpcrp030000-asr_E00396-000TakaraShuzoInternationalGroupReportableSegmentsMember4704000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration_jpcrp030000-asr_E00396-000TakaraBioGroupReportableSegmentsMember6516000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember100000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration_CorporateSharedMember79000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration14165000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember199699743
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember199699743
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant199699743
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant199699743
Number of shares constituting one unitCurrentYearInstant_OrdinaryShareMember100
Number of shareholders national and local governmentsCurrentYearInstant_OrdinaryShareMember-
Number of shareholders financial institutionsCurrentYearInstant_OrdinaryShareMember56
Number of shareholders financial service providersCurrentYearInstant_OrdinaryShareMember35
Number of shareholders other corporationsCurrentYearInstant_OrdinaryShareMember472
Number of shareholders foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember251
Number of shareholders foreign individual investorsCurrentYearInstant_OrdinaryShareMember102
Number of shareholders individuals and othersCurrentYearInstant_OrdinaryShareMember76062
Number of shareholders totalCurrentYearInstant_OrdinaryShareMember76978
Number of shares held number of units national and local governmentsCurrentYearInstant_OrdinaryShareMember-
Number of shares held number of units financial institutionsCurrentYearInstant_OrdinaryShareMember1005288
Number of shares held number of units financial service providersCurrentYearInstant_OrdinaryShareMember54730
Number of shares held number of units other corporationsCurrentYearInstant_OrdinaryShareMember293762
Number of shares held number of units foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember211730
Number of shares held number of units foreign individual investorsCurrentYearInstant_OrdinaryShareMember873
Number of shares held number of units individuals and othersCurrentYearInstant_OrdinaryShareMember429290
Number of shares held number of units totalCurrentYearInstant_OrdinaryShareMember1995673
Number of shares held shares less than one unitCurrentYearInstant_OrdinaryShareMember132443
Percentage of shareholdings national and local governmentsCurrentYearInstant_OrdinaryShareMember-
Percentage of shareholdings financial institutionsCurrentYearInstant_OrdinaryShareMember0.5037
Percentage of shareholdings financial service providersCurrentYearInstant_OrdinaryShareMember0.0274
Percentage of shareholdings other corporationsCurrentYearInstant_OrdinaryShareMember0.1472
Percentage of shareholdings foreigners other than individualsCurrentYearInstant_OrdinaryShareMember0.1061
Percentage of shareholdings foreign individualsCurrentYearInstant_OrdinaryShareMember0.0005
Percentage of shareholdings individuals and othersCurrentYearInstant_OrdinaryShareMember0.2151
Number of shares heldCurrentYearInstant_No1MajorShareholdersMember35910600
Shareholding ratioCurrentYearInstant_No1MajorShareholdersMember0.1816

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2023-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass
balance sheet identitynon_consolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-03-31pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass